Compare CNSP & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNSP | FTEL |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.7M |
| IPO Year | 2019 | 2023 |
| Metric | CNSP | FTEL |
|---|---|---|
| Price | $6.09 | $3.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 73.0K | ★ 425.2K |
| Earning Date | 11-17-2025 | 11-17-2025 |
| Dividend Yield | N/A | ★ 45.45% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,200,138.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.42 |
| 52 Week Low | $4.93 | $2.91 |
| 52 Week High | $114.00 | $1,427.20 |
| Indicator | CNSP | FTEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 73.05 |
| Support Level | $5.75 | $2.96 |
| Resistance Level | $7.51 | $3.50 |
| Average True Range (ATR) | 0.72 | 0.28 |
| MACD | 0.09 | 0.14 |
| Stochastic Oscillator | 22.58 | 90.39 |
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.